JP2024540691A5 - - Google Patents
Info
- Publication number
- JP2024540691A5 JP2024540691A5 JP2024549576A JP2024549576A JP2024540691A5 JP 2024540691 A5 JP2024540691 A5 JP 2024540691A5 JP 2024549576 A JP2024549576 A JP 2024549576A JP 2024549576 A JP2024549576 A JP 2024549576A JP 2024540691 A5 JP2024540691 A5 JP 2024540691A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- conjugate according
- range
- aromatic residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21207195.5 | 2021-11-09 | ||
| EP21207195 | 2021-11-09 | ||
| PCT/EP2022/081345 WO2023083900A1 (en) | 2021-11-09 | 2022-11-09 | Conjugates comprising a phosphorus (v) and a drug moiety |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540691A JP2024540691A (ja) | 2024-10-31 |
| JP2024540691A5 true JP2024540691A5 (cg-RX-API-DMAC7.html) | 2025-11-17 |
Family
ID=78592631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024549576A Pending JP2024540691A (ja) | 2021-11-09 | 2022-11-09 | リン(v)および薬物部分を含むコンジュゲート |
Country Status (15)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL321506A (en) * | 2022-12-22 | 2025-08-01 | Tubulis Gmbh | Conjugates comprising a phosphorus(v) moiety and a drug |
| WO2025027529A1 (en) | 2023-07-31 | 2025-02-06 | Advesya | Anti-il-1rap antibody drug conjugates and methods of use thereof |
| KR20260065883A (ko) | 2023-09-01 | 2026-05-11 | 투불리스 게엠베하 | 포스포나미데이트 화합물의 제조 방법 |
| TW202530255A (zh) | 2023-12-15 | 2025-08-01 | 法商亞維西亞有限公司 | 抗il-1rap結合結構域及其抗體-藥物偶聯物 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| US12521446B2 (en) | 2024-02-27 | 2026-01-13 | Bristol-Myers Squibb Company | Anti-CEACAM5 antibody drug conjugates |
| WO2025262641A1 (en) | 2024-06-19 | 2025-12-26 | Pheon Therapeutics Ltd | Antibody drug conjugates that bind cdcp1 and uses thereof |
| WO2026096695A1 (en) | 2024-10-31 | 2026-05-07 | Bristol-Myers Squibb Company | Anti-fucosyl-gm1 antibody drug conjugates |
| WO2026107136A1 (en) | 2024-11-14 | 2026-05-21 | Bristol-Myers Squibb Company | Anti-ceacam5 antibody drug conjugates for the treatment of cancer |
| WO2026105061A1 (en) | 2024-11-15 | 2026-05-21 | Pheon Therapeutics Ltd | Antibody-drug conjugates that bind cdcp1 and uses thereof |
| US20260144885A1 (en) | 2024-11-22 | 2026-05-28 | Bristol-Myers Squibb Company | Anti-lrrc15 antibodies and uses thereof |
| US20260144884A1 (en) | 2024-11-22 | 2026-05-28 | Bristol-Myers Squibb Company | Anti-lrrc15 antibody drug conjugates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US633410A (en) | 1898-09-22 | 1899-09-19 | George A Ames | Ice-cutter. |
| EP0401384B1 (en) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| JP2763020B2 (ja) | 1995-04-27 | 1998-06-11 | 日本電気株式会社 | 半導体パッケージ及び半導体装置 |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| EP1731174A3 (en) | 1996-08-02 | 2007-01-17 | Ortho-McNeil Pharmaceutical, Inc. | Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond |
| ES2369542T3 (es) | 2002-07-31 | 2011-12-01 | Seattle Genetics, Inc. | Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa. |
| NZ588884A (en) | 2008-04-30 | 2013-05-31 | Immunogen Inc | Cross-linkers and their uses |
| PT3057585T (pt) | 2013-10-15 | 2020-10-21 | Seagen Inc | Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando |
| WO2018041985A1 (en) | 2016-09-01 | 2018-03-08 | Forschungsverbund Berlin E.V. | Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates |
| US12453779B2 (en) | 2018-03-07 | 2025-10-28 | Forschungsverbund Berlin E.V. | Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates |
| TWI920652B (zh) | 2018-06-07 | 2026-04-01 | 美商思進公司 | 喜樹鹼結合物 |
-
2022
- 2022-11-09 US US18/054,018 patent/US20230330258A1/en not_active Abandoned
- 2022-11-09 ES ES22817174T patent/ES2999335T1/es active Pending
- 2022-11-09 CA CA3237371A patent/CA3237371A1/en active Pending
- 2022-11-09 JP JP2024549576A patent/JP2024540691A/ja active Pending
- 2022-11-09 IL IL312675A patent/IL312675A/en unknown
- 2022-11-09 PE PE2024001005A patent/PE20242107A1/es unknown
- 2022-11-09 KR KR1020247019065A patent/KR20240100413A/ko active Pending
- 2022-11-09 MX MX2024005546A patent/MX2024005546A/es unknown
- 2022-11-09 WO PCT/EP2022/081345 patent/WO2023083900A1/en not_active Ceased
- 2022-11-09 EP EP22817174.0A patent/EP4429708A1/en active Pending
- 2022-11-09 AU AU2022385379A patent/AU2022385379A1/en active Pending
- 2022-11-09 DE DE22817174.0T patent/DE22817174T1/de active Pending
- 2022-11-09 CN CN202280074835.4A patent/CN118302197A/zh active Pending
-
2024
- 2024-05-06 CL CL2024001372A patent/CL2024001372A1/es unknown
- 2024-05-06 CO CONC2024/0005877A patent/CO2024005877A2/es unknown
-
2025
- 2025-05-14 US US19/207,970 patent/US20250281634A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7861064B2 (ja) | 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー | |
| US20240173427A1 (en) | Glypican 3 antibodies and conjugates thereof | |
| ES2999335T1 (en) | Conjugates comprising a phosphorus (v) and a drug moiety | |
| JP2023082096A (ja) | エリブリンをベースとする抗体-薬物コンジュゲート及び使用方法 | |
| JP6165168B2 (ja) | 抗糖尿病化合物 | |
| US10004812B2 (en) | Antibody-drug conjugates and immunotoxins | |
| AU2015215015B2 (en) | Antibody-drug conjugates and immunotoxins | |
| JP6585600B2 (ja) | C末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法 | |
| JP2023134472A (ja) | 抗メソセリン抗体およびその抗体薬物コンジュゲート | |
| TW202010498A (zh) | 喜樹鹼肽結合物 | |
| JP2022530524A5 (cg-RX-API-DMAC7.html) | ||
| JP2023515845A (ja) | 抗-cd56抗体-薬物複合体およびその治療での使用 | |
| JP2017537893A5 (cg-RX-API-DMAC7.html) | ||
| TW202203978A (zh) | 電荷可變連接子 | |
| BR112021010364A2 (pt) | Composições farmacêuticas que compreendem conjugados de anticorpo-fármaco anti-191p4d12 e métodos de uso das mesmas | |
| JP2024545170A5 (cg-RX-API-DMAC7.html) | ||
| AU2015340370A9 (en) | Materials and methods relating to linkers for use in protein drug conjugates | |
| JP2024532304A (ja) | 抗体-薬物コンジュゲートを使用する方法 | |
| JP2024529506A (ja) | ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法 | |
| CN120957758A (zh) | 大环化合物及其制备方法和用途 | |
| BR112021005465A2 (pt) | agentes de ligação biespecíficos direcionados ao sindecano-1 e receptor do fator de crescimento de fibroblasto | |
| CA3038427C (en) | Non-linear self-immolative linkers and conjugates thereof | |
| JP2025513664A5 (cg-RX-API-DMAC7.html) | ||
| BR112016018005B1 (pt) | Conjugados anticorpo-droga e imunotoxinas |